SE344166B - - Google Patents

Info

Publication number
SE344166B
SE344166B SE17053/66A SE1705366A SE344166B SE 344166 B SE344166 B SE 344166B SE 17053/66 A SE17053/66 A SE 17053/66A SE 1705366 A SE1705366 A SE 1705366A SE 344166 B SE344166 B SE 344166B
Authority
SE
Sweden
Application number
SE17053/66A
Inventor
L Bjoerk
U Erikson
B Ingelman
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE17053/66A priority Critical patent/SE344166B/xx
Priority to DK610367AA priority patent/DK120954B/da
Priority to FI673306A priority patent/FI47525C/fi
Priority to DE1967P0043585 priority patent/DE1643494B2/de
Priority to NO170938A priority patent/NO121667B/no
Priority to GB56367/67A priority patent/GB1210230A/en
Priority to FR131891A priority patent/FR7251M/fr
Priority to CH1747867A priority patent/CH473586A/fr
Priority to AT11241/67A priority patent/AT278237B/de
Priority to US864167A priority patent/US3678152A/en
Priority to US27437A priority patent/US3692824A/en
Publication of SE344166B publication Critical patent/SE344166B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
SE17053/66A 1966-12-13 1966-12-13 SE344166B (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE17053/66A SE344166B (fr) 1966-12-13 1966-12-13
DK610367AA DK120954B (da) 1966-12-13 1967-12-06 Jodholdige bezoesyrederivater eller salte deraf til anvendelse som røntgenkontrastmidler.
FI673306A FI47525C (fi) 1966-12-13 1967-12-11 Röntgenvarjoaine.
DE1967P0043585 DE1643494B2 (de) 1966-12-13 1967-12-12 N,n'-bis- eckige klammer auf 3- carboxy-5-(n''-acetyl-n''-methylamino)- 2,4,6-trijodphenyl eckige klammer zu -hydroxyalkylendiamine bzw. -hydroxy- oxa-alkylendiamine, verfahren zu deren herstellung und diese verbindungen enthaltende roentgenkontrastmittel
NO170938A NO121667B (fr) 1966-12-13 1967-12-12
GB56367/67A GB1210230A (en) 1966-12-13 1967-12-12 Bis (acyl-substituted amine-triiodobenzoic acid) compounds for use in x-ray visualization
FR131891A FR7251M (fr) 1966-12-13 1967-12-12
CH1747867A CH473586A (fr) 1966-12-13 1967-12-13 Procédé d'examen radiologique des cavités du corps et composition pour sa mise en oeuvre
AT11241/67A AT278237B (de) 1966-12-13 1967-12-13 Roentgenkontrastmittel
US864167A US3678152A (en) 1966-12-13 1969-10-06 Method for the x-ray visualization of body cavities and a preparation for carrying out the method
US27437A US3692824A (en) 1966-12-13 1970-04-10 Novel 3,5-substituted 2,4,6-triiodobenzoic acids and salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE17053/66A SE344166B (fr) 1966-12-13 1966-12-13

Publications (1)

Publication Number Publication Date
SE344166B true SE344166B (fr) 1972-04-04

Family

ID=20303185

Family Applications (1)

Application Number Title Priority Date Filing Date
SE17053/66A SE344166B (fr) 1966-12-13 1966-12-13

Country Status (10)

Country Link
US (2) US3678152A (fr)
AT (1) AT278237B (fr)
CH (1) CH473586A (fr)
DE (1) DE1643494B2 (fr)
DK (1) DK120954B (fr)
FI (1) FI47525C (fr)
FR (1) FR7251M (fr)
GB (1) GB1210230A (fr)
NO (1) NO121667B (fr)
SE (1) SE344166B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780875B2 (en) 2005-01-13 2010-08-24 Cinvention Ag Composite materials containing carbon nanoparticles

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1193211B (it) * 1979-08-09 1988-06-15 Bracco Ind Chimica Spa Derivati dell'acido 2,4,6-triiodo-isoftalico,metodo per la loro preparazione e mezzi di contrasto che li contengono
IT1207226B (it) * 1979-08-09 1989-05-17 Bracco Ind Chimica Spa Derivati dell'acido 2,4,6-triiodo-isoftalico, metodo per la loro preparazione e mezzi di contrasto che li contengono.
ATE20733T1 (de) * 1982-11-08 1986-08-15 Nyegaard & Co As Roentgenkontrastmittel.
EP2104473A1 (fr) * 2007-01-19 2009-09-30 Cinvention Ag Implant poreux non dégradable réalisé à l'aide d'un moulage de poudre
JP5340281B2 (ja) 2007-07-12 2013-11-13 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
CN101820924A (zh) 2007-10-12 2010-09-01 通用电气医疗集团股份有限公司 造影剂
ES2413160T3 (es) 2007-10-12 2013-07-15 Ge Healthcare As Agentes de contraste
JP2011500533A (ja) 2007-10-12 2011-01-06 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
EP2200655B1 (fr) 2007-10-12 2012-07-18 GE Healthcare AS Produits de contraste
CN107249570B (zh) 2014-11-21 2022-08-09 丹麦技术大学 用于局部药物释放的凝胶制剂
AU2017266410B2 (en) 2016-05-20 2022-07-14 Nanovi Radiotherapy Aps Palpable marker composition
WO2020249801A1 (fr) 2019-06-12 2020-12-17 Technical University Of Denmark Formulations de disaccharides pour la libération contrôlée de médicaments

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178473A (en) * 1962-03-02 1965-04-13 Nyegaard & Co As Process for the n-alkylation of acyl anilides halogen substituted in the nucleus
GB1033777A (en) * 1963-06-06 1966-06-22 Sterling Drug Inc Bis-anilide derivatives
US3542861A (en) * 1967-05-08 1970-11-24 Sterling Drug Inc 3-amino-5-cycloalkylcarbonylamino-2,4,6-triiodobenzoic acids

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780875B2 (en) 2005-01-13 2010-08-24 Cinvention Ag Composite materials containing carbon nanoparticles

Also Published As

Publication number Publication date
US3692824A (en) 1972-09-19
AT278237B (de) 1970-01-26
GB1210230A (en) 1970-10-28
US3678152A (en) 1972-07-18
DE1643494A1 (de) 1971-07-15
NO121667B (fr) 1971-03-29
FI47525C (fi) 1974-01-10
DE1643494B2 (de) 1976-10-14
FR7251M (fr) 1969-09-08
CH473586A (fr) 1969-06-15
DK120954B (da) 1971-08-09
FI47525B (fr) 1973-10-01

Similar Documents

Publication Publication Date Title
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
AU421822B2 (fr)
AU612166A (fr)
AU5895065A (fr)
AU1111066A (fr)
AU1144366A (fr)
AU218666A (fr)
AU6703465A (fr)
AU92366A (fr)
BE475118A (fr)
AU414093B2 (fr)
AU433620A (fr)
AU407778B2 (fr)
AU415780B2 (fr)
BE618801A (fr)
BE687348A (fr)
BE691727A (fr)
AU2390066A (fr)